Improvement effect of oryzanolum on endocrine disorder of perimenopausal women
Author(s): CAO Ying-Dong, TAO Zhen-Lan, Haikou Maternal and Child Health Care Hospital
Pages: 5415-5418
Year: 2016 Issue: 24
Journal: Maternal and Child Health Care of China
Keyword: Oryzanol; Perimenopausal woman; Endocrine disorder;
Abstract: Objective To research the improvement effect of oryzanolum on endocrine disorder of perimenopausal women. Methods A total of 120 perimenopausal women were selected from the hospital from October 2014 to October 2015,then they were randomly divided into observation group and control group,60 perimenopausal women in each group. The perimenopausal women in control group were given routine treatment,and the perimenopausal women in observation group were given oryzanol treatment. The levels of estradiol( E2),follicle- stimulating hormone( FSH),luteinizing hormone( LH),total cholesterol,triglyceride,high- density lipoprotein cholesterol,low- density lipoprotein cholesterol and curative effects after treatment in the two groups were observed. Results After treatment,E2 level in observation group was(68. 25 ± 8. 01) pmol / L,which was higher than that in control group [(52. 09 ± 7. 23) pmol / L]; FSH and LH levels in observation group were(34. 12 ± 5. 69) U / L and(38. 03 ± 10. 01) U / L,respectively,which were statistically significantly lower than those in control group[(46. 10 ±7. 02) U/L and(45. 83 ± 11. 05) U/L](P < 0. 05); the levels of total cholesterol and triglyceride in observation group were(7. 56 ±1. 23) mmol/L and(3. 02 ± 1. 01) mmol/L,respectively,which were statistically significantly lower than those in control group[(8. 97 ±2. 13) mmol/L and(5. 97 ±1. 28) mmol/L](P <0. 05); the levels of high- density lipoprotein cholesterol and low- density lipoprotein cholesterol in observation group were(2. 37 ± 0. 52) g / L and(1. 80 ± 0. 57) g / L,respectively,which were statistically significantly better than those in control group [(2. 06 ± 0. 51) g / L and(2. 15 ± 0. 46) g / L]( P < 0. 05); The improvement time of upset hot sweating,insomnia,irritability,and pother in observation group were( 12. 09 ± 3. 01) days,( 14. 01 ± 2. 10) days,( 10. 20 ± 2. 13) days,and(13. 09 ±2. 72) days,respectively,which were statistically significantly shorter than that in control group [(21. 03 ±6. 23) days,(19. 52 ±5. 10) days,(19. 70 ± 6. 10) days,(20. 17 ± 6. 08) days]( P < 0. 05); the total effective rate in observation group was 95. 00%(57 /60),which was statistically significantly higher than that in control group(68. 33%,41 /60)( P < 0. 05). Conclusion The curative effect of oryzanol in treatment of endocrine disorder of perimenopausal women is significant,and the levels of E2,FSH,and LH in these women return to normal.
Pages: 5415-5418
Year: 2016 Issue: 24
Journal: Maternal and Child Health Care of China
Keyword: Oryzanol; Perimenopausal woman; Endocrine disorder;
Abstract: Objective To research the improvement effect of oryzanolum on endocrine disorder of perimenopausal women. Methods A total of 120 perimenopausal women were selected from the hospital from October 2014 to October 2015,then they were randomly divided into observation group and control group,60 perimenopausal women in each group. The perimenopausal women in control group were given routine treatment,and the perimenopausal women in observation group were given oryzanol treatment. The levels of estradiol( E2),follicle- stimulating hormone( FSH),luteinizing hormone( LH),total cholesterol,triglyceride,high- density lipoprotein cholesterol,low- density lipoprotein cholesterol and curative effects after treatment in the two groups were observed. Results After treatment,E2 level in observation group was(68. 25 ± 8. 01) pmol / L,which was higher than that in control group [(52. 09 ± 7. 23) pmol / L]; FSH and LH levels in observation group were(34. 12 ± 5. 69) U / L and(38. 03 ± 10. 01) U / L,respectively,which were statistically significantly lower than those in control group[(46. 10 ±7. 02) U/L and(45. 83 ± 11. 05) U/L](P < 0. 05); the levels of total cholesterol and triglyceride in observation group were(7. 56 ±1. 23) mmol/L and(3. 02 ± 1. 01) mmol/L,respectively,which were statistically significantly lower than those in control group[(8. 97 ±2. 13) mmol/L and(5. 97 ±1. 28) mmol/L](P <0. 05); the levels of high- density lipoprotein cholesterol and low- density lipoprotein cholesterol in observation group were(2. 37 ± 0. 52) g / L and(1. 80 ± 0. 57) g / L,respectively,which were statistically significantly better than those in control group [(2. 06 ± 0. 51) g / L and(2. 15 ± 0. 46) g / L]( P < 0. 05); The improvement time of upset hot sweating,insomnia,irritability,and pother in observation group were( 12. 09 ± 3. 01) days,( 14. 01 ± 2. 10) days,( 10. 20 ± 2. 13) days,and(13. 09 ±2. 72) days,respectively,which were statistically significantly shorter than that in control group [(21. 03 ±6. 23) days,(19. 52 ±5. 10) days,(19. 70 ± 6. 10) days,(20. 17 ± 6. 08) days]( P < 0. 05); the total effective rate in observation group was 95. 00%(57 /60),which was statistically significantly higher than that in control group(68. 33%,41 /60)( P < 0. 05). Conclusion The curative effect of oryzanol in treatment of endocrine disorder of perimenopausal women is significant,and the levels of E2,FSH,and LH in these women return to normal.
Related Articles